HighVista Strategies’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
40,864
-13,326
| -25% | -$378K | 0.43% | 100 |
|
|
2025
Q1 | $1.6M | Hold |
54,190
| – | – | 0.62% | 61 |
|
|
2024
Q4 | $1.58M | Buy |
54,190
+41,686
| +333% | +$1.21M | 0.59% | 60 |
|
|
2024
Q3 | $574K | Buy |
+12,504
| New | +$574K | 0.2% | 115 |
|
|
2023
Q2 | – | Sell |
-16,733
| Closed | -$257K | – | 150 |
|
|
2023
Q1 | $257K | Buy |
+16,733
| New | +$257K | 0.21% | 97 |
|
|
2022
Q4 | – | Sell |
-17,334
| Closed | -$283K | – | 123 |
|
|
2022
Q3 | $283K | Sell |
17,334
-7,530
| -30% | -$123K | 0.16% | 96 |
|
|
2022
Q2 | $361K | Sell |
24,864
-28,300
| -53% | -$411K | 0.22% | 85 |
|
|
2022
Q1 | $982K | Buy |
53,164
+8,870
| +20% | +$164K | 0.62% | 34 |
|
|
2021
Q4 | $1.05M | Sell |
44,294
-12,558
| -22% | -$299K | 0.84% | 43 |
|
|
2021
Q3 | $1.4M | Buy |
+56,852
| New | +$1.4M | 0.93% | 22 |
|
|
2021
Q2 | – | Sell |
-31,797
| Closed | -$693K | – | 135 |
|
|
2021
Q1 | $693K | Buy |
31,797
+5,132
| +19% | +$112K | 0.52% | 40 |
|
|
2020
Q4 | $680K | Buy |
26,665
+9,463
| +55% | +$241K | 0.43% | 56 |
|
|
2020
Q3 | $484K | Buy |
+17,202
| New | +$484K | 0.35% | 51 |
|